Ophthalmic Clinical Trials Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Phase (Discovery Phase, Preclinical Phase, Clinical Phase), By Indication, By Sponsor Type, By Region, And Segment Forecasts, 2023

The global ophthalmic clinical trials market size is expected to reach USD 2.5 billion by 2030 at a CAGR of 6.6% over the forecast period, according to a new report by Grand View Research, Inc. Technological developments and a rising need for more efficient eye disease treatments are driving the market for ophthalmology clinical trials to expand quickly. Pharmaceutical firms, medical equipment producers, and Contract Research Organizations (CROs) are a few of the major contributors to this sector.

The rising incidence of eye conditions, including glaucoma, macular degeneration, and diabetic retinopathy, is driving the industry. As the global population ages and eye illnesses become more common, the market for ophthalmology clinical trials is further anticipated to grow in the coming years. Additionally, developments in genetic research and personalized medicine are likely to spur innovation in this area, creating more specialized and efficient treatments for eye illnesses.

The demand for clinical trials will rise due to the increasing focus of ophthalmic researchers to develop and market novel ocular medicines. Furthermore, the initiatives adopted to fulfill the unmet needs in developing economies regarding rare ocular conditions are anticipated to support the growth of the ophthalmology clinical trials market. For instance, nearly 2.2 billion people are estimated to have separation or close-up vision impairment disorders, and of these, at least half, or 1 billion cases, can be avoided with the aid of appropriate treatment, according to the World Health Organization's October 2021 report on visually impaired people's impairment.

The COVID-19 pandemic has significantly impacted the ophthalmology clinical trials market. Clinical trials have been hampered by the epidemic, which has delayed the start of new trials and slowed patient enrollment. Additionally, several clinical study locations had to close, significantly reducing patient visits and data collecting. The epidemic has hastened the deployment of remote and virtual clinical trial technology, allowing for the continuation of ongoing trials and the start of new ones. Some of the difficulties brought on by the pandemic, including travel limitations and social seclusion requirements, have been mitigated partly by adopting these technologies.

Ophthalmic Clinical Trials Market Highlights

The drug segment accounted for the largest share of 75.5% in 2022. The segment dominated the market owing to the growing demand for innovative and efficient drug therapies for various eye ailments
The Glaucoma segment is expected to witness the highest CAGR of 7.3% during the analysis timeframe. The increase in collaboration and partnerships among the key players for developing novel glaucoma products spurs the segment's growth
The clinical phase segment dominated the market in 2022 with a revenue share of 79.4%. Increasing investments in R&D by the government, as well as private entities for the conduct of clinical studies, drives the segment's growth
The pharmaceutical/biopharmaceutical companies segment dominated the market in 2022 with a revenue share of 41.8%. The major sponsors of ophthalmology clinical trials are pharmaceutical and biopharmaceutical companies since they have the resources and knowledge to create and commercialize novel treatments
Asia Pacific is anticipated to register a lucrative CAGR of 7.2% during the analysis period. This is primarily due to a huge patient pool willing to undergo clinical trials. Furthermore, the cost-effective nature of clinical trials across developing economies such as India has further attracted Western countries to conduct clinical research, thereby boosting the region's growth in the ophthalmic clinical trials market

Product Code: GVR-4-68040-085-8

Table of contents

Chapter 1. Research Methodology And Scope

1.1. Market Segmentation & Scope
- 1.1.1. Segment Definitions
- 1.1.2. Product
- 1.1.3. Indication
- 1.1.4. Phase
- 1.1.5. Sponsor Type
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
1.5. Research Methodology
1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
1.7. Information Or Data Analysis
- 1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Ophthalmic Clinical Trials Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing Partnerships Between CROs And Drug Development Companies To Boost The Market Growth
  - 3.2.1.2. Growing Research Funding Pertaining To Ocular Therapeutics Is Another Prominent Factor Supporting The Growth Of The Ophthalmic Clinical Trials Market.
  - 3.2.1.3. Technological Innovations Pertaining to Ophthalmic Research to Boost The Market Growth
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Low Barriers to Market Penetration Have Resulted In Pricing Pressure
  - 3.2.2.2. Challenges Related to Quality Control
3.3. Ophthalmic Clinical Trials Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier Power
  - 3.3.1.2. Buyer Power
  - 3.3.1.3. Substitution Threat
  - 3.3.1.4. Threat Of New Entrant
  - 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis

Chapter 4. Ophthalmic Clinical Trials Market: Product Estimates & Trend Analysis

4.1. Ophthalmic Clinical Trials Market, By Product: Segment Dashboard
4.2. Ophthalmic Clinical Trials Market, By Product: Movement Analysis
4.3. Ophthalmic Clinical Trials Market Estimates & Forecasts, By Product, 2018 - 2030
- 4.3.1. Devices
  - 4.3.1.1. Devices Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
  - 4.3.1.2. Surgical & Diagnostics Devices
  - 4.3.1.2.1. Surgical & Diagnostics Devices Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
  - 4.3.1.3. Vision Care Devices
  - 4.3.1.3.1. Vision Care Devices Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 4.3.2. Drugs
  - 4.3.2.1. Drugs Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
  - 4.3.2.2. OTC Drugs
  - 4.3.2.2.1. OTC Drugs Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
  - 4.3.2.3. Prescription Drugs
  - 4.3.2.3.1. Prescription Drugs Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)

Chapter 5. Ophthalmic Clinical Trials Market: Indication Estimates & Trend Analysis

5.1. Ophthalmic Clinical Trials Market, By Indication: Segment Dashboard
5.2. Ophthalmic Clinical Trials Market, By Indication: Movement Analysis
5.3. Ophthalmic Clinical Trials Market Estimates & Forecasts, By Indication, 2018 - 2030
- 5.3.1. Macular Degeneration
  - 5.3.1.1. Macular Degeneration Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.2. Glaucoma
  - 5.3.2.1. Glaucoma Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.3. Dry Eye Disease
  - 5.3.3.1. Dry Eye Disease Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.4. Retinopathy
  - 5.3.4.1. Retinopathy Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.5. Uveitis
  - 5.3.5.1. Uveitis Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.6. Macular Edema
  - 5.3.6.1. Macular Edema Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.7. Blepharitis
  - 5.3.7.1. Blepharitis Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.8. Cataract
  - 5.3.8.1. Cataract Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.9. Optic Neuropathy
  - 5.3.9.1. Optic Neuropathy Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)
- 5.3.10. Others
  - 5.3.10.1. Others Ophthalmic Clinical Trials Market, 2018 to 2030 (USD Million)

Chapter 6. Ophthalmic Clinical Trials Market: Phase Estimates & Trend Analysis

6.1. Ophthalmic Clinical Trials Market, By Phase: Segment Dashboard
6.2. Ophthalmic Clinical Trials Market, By Phase: Movement Analysis
6.3. Ophthalmic Clinical Trials Market Estimates & Forecasts, By Phase, 2018 - 2030
- 6.3.1. Discovery Phase
  - 6.3.1.1. Discovery Phase Ophthalmic Clinical Trials Market 2018 to 2030 (USD Million)
- 6.3.2. Preclinical Phase
  - 6.3.2.1. Preclinical Phase Ophthalmic Clinical Trials Market 2018 to 2030 (USD Million)
- 6.3.3. Clinical Phase
  - 6.3.3.1. Clinical Phase Ophthalmic Clinical Trials Market 2018 to 2030 (USD Million)

Chapter 7. Ophthalmic Clinical Trials Market: Sponsor Type Estimates & Trend Analysis

7.1. Ophthalmic Clinical Trials Market, By Sponsor Type: Segment Dashboard
7.2. Ophthalmic Clinical Trials Market, By Sponsor Type: Movement Analysis
7.3. Ophthalmic Clinical Trials Market Estimates & Forecasts, By Phase, 2018 - 2030
- 7.3.1. Pharmaceutical/biopharmaceutical Companies
  - 7.3.1.1. Pharmaceutical/biopharmaceutical Companies Ophthalmic Clinical Trials Market 2018 to 2030 (USD Million)
- 7.3.2. Medical Device Companies
  - 7.3.2.1. Medical Device Companies Ophthalmic Clinical Trials Market 2018 to 2030 (USD Million)
- 7.3.3. Others
  - 7.3.3.1. Others Ophthalmic Clinical Trials Market 2018 to 2030 (USD Million)

Chapter 8. Ophthalmic Clinical Trials Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2022 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. North America
- 8.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Competitive Scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
- 8.4.3. Canada
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Competitive Scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
8.5. Europe
- 8.5.1. UK
  - 8.5.1.1. Key Country Dynamics
  - 8.5.1.2. Competitive Scenario
  - 8.5.1.3. Regulatory Framework
  - 8.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
- 8.5.2. Germany
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Competitive Scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
- 8.5.3. France
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Competitive Scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
- 8.5.4. Italy
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Competitive Scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
- 8.5.5. Spain
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Competitive Scenario
  - 8.5.5.3. Regulatory Framework
  - 8.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
- 8.5.6. Denmark
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Competitive Scenario
  - 8.5.6.3. Regulatory Framework
  - 8.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
- 8.5.7. Sweden
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Competitive Scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
- 8.5.8. Norway
  - 8.5.8.1. Key Country Dynamics
  - 8.5.8.2. Competitive Scenario
  - 8.5.8.3. Regulatory Framework
  - 8.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
8.6. Asia Pacific
- 8.6.1. Japan
  - 8.6.1.1. Key Country Dynamics
  - 8.6.1.2. Competitive Scenario
  - 8.6.1.3. Regulatory Framework
  - 8.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
- 8.6.2. India
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Competitive Scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
- 8.6.3. China
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Competitive Scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
- 8.6.4. South Korea
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Competitive Scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
- 8.6.5. Australia
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Competitive Scenario
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
- 8.6.6. Thailand
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Competitive Scenario
  - 8.6.6.3. Regulatory Framework
  - 8.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
8.7. Latin America
- 8.7.1. Brazil
  - 8.7.1.1. Key Country Dynamics
  - 8.7.1.2. Competitive Scenario
  - 8.7.1.3. Regulatory Framework
  - 8.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
- 8.7.2. Mexico
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Competitive Scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
- 8.7.3. Argentina
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Competitive Scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
8.8. MEA
- 8.8.1. South Africa
  - 8.8.1.1. Key Country Dynamics
  - 8.8.1.2. Competitive Scenario
  - 8.8.1.3. Regulatory Framework
  - 8.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
- 8.8.2. Saudi Arabia
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Competitive Scenario
  - 8.8.2.3. Regulatory Framework
  - 8.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
- 8.8.3. UAE
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Competitive Scenario
  - 8.8.3.3. Regulatory Framework
  - 8.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
- 8.8.4. Kuwait
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Competitive Scenario
  - 8.8.4.3. Regulatory Framework
  - 8.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030

Chapter 9. Competitive Landscape

9.1. Market Participant Categorization
- 9.1.1. Innovators
- 9.1.2. Market Leaders
- 9.1.3. Emerging Players
- 9.1.4. Company Market Share Analysis, 2022
9.2. Company Profiles
- 9.2.1. Charles River Laboratories International, Inc
  - 9.2.1.1. Company Overview
  - 9.2.1.2. Financial Performance
  - 9.2.1.3. Service Benchmarking
  - 9.2.1.4. Strategic Initiatives
- 9.2.2. Laboratory Corporation of America Holdings
  - 9.2.2.1. Company Overview
  - 9.2.2.2. Financial Performance
  - 9.2.2.3. Service Benchmarking
  - 9.2.2.4. Strategic Initiatives
- 9.2.3. IQVIA
  - 9.2.3.1. Company Overview
  - 9.2.3.2. Financial Performance
  - 9.2.3.3. Service Benchmarking
  - 9.2.3.4. Strategic Initiatives
- 9.2.4. ICON Plc
  - 9.2.4.1. Company Overview
  - 9.2.4.2. Financial Performance
  - 9.2.4.3. Service Benchmarking
  - 9.2.4.4. Strategic Initiatives
- 9.2.5. Vial
  - 9.2.5.1. Company Overview
  - 9.2.5.2. Financial Performance
  - 9.2.5.3. Service Benchmarking
  - 9.2.5.4. Strategic Initiatives
- 9.2.6. Medpace
  - 9.2.6.1. Company Overview
  - 9.2.6.2. Financial Performance
  - 9.2.6.3. Service Benchmarking
  - 9.2.6.4. Strategic Initiatives
- 9.2.7. ProTrials Research, Inc.
  - 9.2.7.1. Company Overview
  - 9.2.7.2. Financial Performance
  - 9.2.7.3. Service Benchmarking
  - 9.2.7.4. Strategic Initiatives
- 9.2.8. Syneos Health
  - 9.2.8.1. Company Overview
  - 9.2.8.2. Financial Performance
  - 9.2.8.3. Service Benchmarking
  - 9.2.8.4. Strategic Initiatives
- 9.2.9. Worldwide Clinical Trials, Inc
  - 9.2.9.1. Company Overview
  - 9.2.9.2. Financial Performance
  - 9.2.9.3. Service Benchmarking
  - 9.2.9.4. Strategic Initiatives
- 9.2.10. ProRelix Services LLP.
  - 9.2.10.1. Company Overview
  - 9.2.10.2. Financial Performance
  - 9.2.10.3. Service Benchmarking
  - 9.2.10.4. Strategic Initiatives

Product Code: GVR-4-68040-085-8

List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Ophthalmic Clinical Trials market, by region, 2018 - 2030 (USD Million)
Table 4 North America Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 5 North America Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 6 North America Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 7 North America Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 8 U.S. Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 9 U.S. Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 10 U.S. Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 11 U.S. Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 12 Canada Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 13 Canada Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 14 Canada Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 15 Canada Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 16 Europe Ophthalmic Clinical Trials market, by region, 2018 - 2030 (USD Million)
Table 17 Europe Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 18 Europe Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 19 Europe Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 20 Europe Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 21 UK Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 22 UK Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 23 UK Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 24 UK Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 25 Germany Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 26 Germany Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 27 Germany Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 28 Germany Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 29 France Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 30 France Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 31 France Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 32 France Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 33 Italy Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 34 Italy Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 35 Italy Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 36 Italy Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 37 Spain Ophthalmic Clinical Trials market, by Dosage Form type, 2018 - 2030 (USD Million)
Table 38 Spain Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 39 Spain Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 40 Spain Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 41 Denmark Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 42 Denmark Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 43 Denmark Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 44 Denmark Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 45 Sweden Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 46 Sweden Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 47 Sweden Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 48 Sweden Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 49 Norway Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 50 Norway Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 51 Norway Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 52 Norway Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 53 Asia Pacific Ophthalmic Clinical Trials market, by region, 2018 - 2030 (USD Million)
Table 54 Asia Pacific Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 55 Asia Pacific Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 56 Asia Pacific Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 58 China Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 59 China Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 60 China Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 61 China Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 62 Japan Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 63 Japan Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 64 Japan Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 65 Japan Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 66 India Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 67 India Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 68 India Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 69 India Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 70 Australia Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 71 Australia Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 72 Australia Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 73 Australia Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 74 South Korea Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 75 South Korea Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 76 South Korea Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 77 South Korea Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 78 Thailand Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 79 Thailand Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 80 Thailand Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 81 Thailand Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 82 Latin America Ophthalmic Clinical Trials market, by region, 2018 - 2030 (USD Million)
Table 83 Latin America Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 84 Latin America Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 85 Latin America Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 86 Latin America Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 87 Brazil Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 88 Brazil Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 89 Brazil Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 90 Brazil Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 91 Mexico Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 92 Mexico Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 93 Mexico Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 94 Mexico Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 95 Argentina Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 96 Argentina Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 97 Argentina Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 98 Argentina Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa Ophthalmic Clinical Trials market, by region, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 103 Middle East and Africa Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 104 South Africa Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 105 South Africa Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 106 South Africa Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 107 South Africa Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 111 South Arabia Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 112 UAE Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 113 UAE Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 114 UAE Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 115 UAE Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)
Table 116 Kuwait Ophthalmic Clinical Trials market, by Product, 2018 - 2030 (USD Million)
Table 117 Kuwait Ophthalmic Clinical Trials market, by Indication, 2018 - 2030 (USD Million)
Table 118 Kuwait Ophthalmic Clinical Trials market, by Phase, 2018 - 2030 (USD Million)
Table 119 Kuwait Ophthalmic Clinical Trials market, by Sponsor Type, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modelling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary interviews in Europe
Fig. 10 Primary interviews in Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Segment Snapshot
Fig. 16 Competitive Landscape Snapshot
Fig. 17 Ophthalmic Clinical Trials market segmentation
Fig. 18 Parent market outlook (2022)
Fig. 19 Related/ancillary market outlook (2022)
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Current shared services and outsourcing usage levels
Fig. 22 Market restraint relevance analysis (Current & future impact)
Fig. 23 Porter's five forces analysis
Fig. 24 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 25 Ophthalmic Clinical Trials Market Product outlook: Segment dashboard
Fig. 26 Ophthalmic Clinical Trials : Product movement analysis
Fig. 27 Devices market, 2018 - 2030 (USD Million)
Fig. 28 Drugs market, 2018 - 2030 (USD Million)
Fig. 29 Ophthalmic Clinical Trials Market Indication outlook: Segment dashboard
Fig. 30 Ophthalmic Clinical Trials : Indication movement analysis
Fig. 31 Macular Degeneration market, 2018 - 2030 (USD Million)
Fig. 32 Glaucoma market, 2018 - 2030 (USD Million)
Fig. 33 Dry eye diseases market, 2018 - 2030 (USD Million)
Fig. 34 Retinopathy market, 2018 - 2030 (USD Million)
Fig. 35 Uveitis market, 2018 - 2030 (USD Million)
Fig. 36 Macular Edema market, 2018 - 2030 (USD Million)
Fig. 37 Blepharitis market, 2018 - 2030 (USD Million)
Fig. 38 Cataract market, 2018 - 2030 (USD Million)
Fig. 39 Optic neuropathy market, 2018 - 2030 (USD Million)
Fig. 40 Others market, 2018 - 2030 (USD Million)
Fig. 41 Ophthalmic Clinical Trials market Phase outlook: Segment dashboard
Fig. 42 Ophthalmic Clinical Trials market: Phase movement analysis
Fig. 43 Discovery phase market, 2018 - 2030 (USD Million)
Fig. 44 Preclinical phase market, 2018 - 2030 (USD Million)
Fig. 45 Clinical phase market, 2018 - 2030 (USD Million)
Fig. 46 Ophthalmic Clinical Trials market Sponsor type outlook: Segment dashboard
Fig. 47 Ophthalmic Clinical Trials market: Sponsor type movement analysis
Fig. 48 Pharmaceutical/ Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 49 Medical device companies market, 2018 - 2030 (USD Million)
Fig. 50 Others market, 2018 - 2030 (USD Million)
Fig. 51 Regional marketplace: Segment dashboard
Fig. 52 Regional outlook, 2022 & 2030
Fig. 53 North America market, 2018 - 2030 (USD Million)
Fig. 54 U.S. market, 2018 - 2030 (USD Million)
Fig. 55 Canada market, 2018 - 2030 (USD Million)
Fig. 56 Europe market, 2018 - 2030 (USD Million)
Fig. 57 Germany market, 2018 - 2030 (USD Million)
Fig. 58 UK market, 2018 - 2030 (USD Million)
Fig. 59 France market, 2018 - 2030 (USD Million)
Fig. 60 Italy market, 2018 - 2030 (USD Million)
Fig. 61 Spain market, 2018 - 2030 (USD Million)
Fig. 62 Denmark market, 2018 - 2030(USD Million)
Fig. 63 Sweden market, 2018 - 2030 (USD Million)
Fig. 64 Norway market, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 66 China market, 2018 - 2030 (USD Million)
Fig. 67 Japan market, 2018 - 2030 (USD Million)
Fig. 68 India market, 2018 - 2030 (USD Million)
Fig. 69 Australia market, 2018 - 2030 (USD Million)
Fig. 70 South Korea market, 2018 - 2030 (USD Million)
Fig. 71 Thailand Markey, 2018 - 2030 (USD Million)
Fig. 71 Latin America market, 2018 - 2030 (USD Million)
Fig. 72 Brazil market, 2018 - 2030 (USD Million)
Fig. 73 Mexico market, 2018 - 2030 (USD Million)
Fig. 74 Argentina market, 2018 - 2030 (USD Million)
Fig. 75 Middle East & Africa market, 2018 - 2030 (USD Million)
Fig. 76 South Africa market, 2018 - 2030 (USD Million)
Fig. 77 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 78 UAE market, 2018 - 2030 (USD Million)
Fig. 79 Kuwait market, 2018 - 2030 (USD Million)

Ophthalmic Clinical Trials Market Size, Share & Trends Analysis Report By Product (Devices, Drugs), By Phase (Discovery Phase, Preclinical Phase, Clinical Phase), By Indication, By Sponsor Type, By Region, And Segment Forecasts, 2023 - 2030

Description

Table of Contents

List of Tables

Ophthalmic Clinical Trials Market Growth & Trends

Chapter 1. Research Methodology And Scope

Chapter 2. Executive Summary

Chapter 3. Ophthalmic Clinical Trials Market Variables, Trends & Scope

Chapter 4. Ophthalmic Clinical Trials Market: Product Estimates & Trend Analysis

Chapter 5. Ophthalmic Clinical Trials Market: Indication Estimates & Trend Analysis

Chapter 6. Ophthalmic Clinical Trials Market: Phase Estimates & Trend Analysis

Chapter 7. Ophthalmic Clinical Trials Market: Sponsor Type Estimates & Trend Analysis

Chapter 8. Ophthalmic Clinical Trials Market: Regional Estimates & Trend Analysis

Chapter 9. Competitive Landscape

List of Tables

List of Figures